Functional analysis and case-control study of -160C/A polymorphism in the E-cadherin gene promoter: Association with cancer risk

Anticancer Research

Volumn 26, Issue 6 B, 2006, Pages 4627-4632

  Cattaneo, Francesca ^a   Venesio, Tiziana ^b   Molatore, Sara ^a   Russo, Antonio ^c   Fiocca, Roberto ^d   Frattini, Milo ^e   Scovassi, A Ivana ^f   Ottini, Laura ^g   Bertario, Lucio ^e   Ranzani, Guglielmina Nadia ^a  

^a UNIVERSITY OF PAVIA   (Italy)

^b CANDIOLO CANCER INSTITUTE   (Italy)

^c Local Health Authority   (Italy)

^d UNIVERSITY OF GENOA   (Italy)

^e NATIONAL CANCER INSTITUTE   (Italy)

^f CNR   (Italy)

^g SAPIENZA UNIVERSITY OF ROME   (Italy)

Author keywords

Cancer risk; CDH1 gene; Epithelial cells; Polymorphism; Promoter

Indexed keywords

LUCIFERASE; UVOMORULIN;

ADULT; AGED; ARTICLE; BREAST CANCER; CANCER RISK; COLORECTAL CANCER; CONTROLLED STUDY; ENDOMETRIUM CANCER; FEMALE; FUNCTIONAL ASSESSMENT; GENETIC ASSOCIATION; GENETIC POLYMORPHISM; GENETIC TRANSCRIPTION; GENOTYPE; HUMAN; HUMAN CELL; MAJOR CLINICAL STUDY; MALE; PRIORITY JOURNAL; PROMOTER REGION; REPORTER GENE; STOMACH CANCER; UTERINE CERVIX CANCER;

BASE SEQUENCE; CADHERINS; CASE-CONTROL STUDIES; DNA PRIMERS; GENOTYPE; HELA CELLS; HUMANS; POLYMORPHISM, GENETIC; PROMOTER REGIONS (GENETICS); RISK FACTORS;

EID: 33845953621     PISSN: 02507005     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (30)

1. Dumitrescu RG and Cotarla I: Understanding breast cancer risk - where do we stand in 2005? J Cell Mol Med 9: 208-221, 2005.
2. de la Chapelle A: Genetic predisposition to colorectal cancer. Nat Rev Cancer 4: 769-780, 2004.
3. Little J, Bradley L, Bray MS, Clyne M, Dorman J, Ellsworth DL, Hanson J, Khoury M, Lau J, O'Brien TR, Rothman N, Stroup D, Taioli E, Thomas D, Vainio H, Wacholder S and Weinberg C: Reporting, appraising, and integrating data on genotype prevalence and gene-disease associations. Am J Epidemiol 156: 300-310, 2002.
4. Kemler R: From cadherins to catenins: cytoplasmic protein interactions and regulation of cell adhesion. Trends Genet 9: 317-321, 1993.
5. Guilford P, Hopkins J, Harraway J, McLeod M, McLeod N, Harawira P, Taite H, Scoular R, Miller A and Reeve AE: E-cadherin germline mutations in familial gastric cancer. Nature 392: 402-405, 1998.
6. Keller G, Vogelsang H, Becker I, Hutter J, Ott K, Candidus S, Grundei T, Becker KF, Mueller J, Siewert JR and Hofler H: Diffuse type gastric and lobular breast carcinoma in a familial gastric cancer patient with an E-cadherin germline mutation. Am J Pathol 155: 337-342, 1999.
7. Yoshiura K, Kanai Y, Ochiai A, Shimoyama Y, Sugimura T and Hirohashi S: Silencing of the E-cadherin invasion-suppressor gene by CpG methylation in human carcinomas. Proc Natl Acad Sci USA 92: 7416-7419, 1995.
8. Oda, T, Kanai Y, Oyama T, Yoshiura K, Shimoyama Y, Birchmeier W, Sugimura T and Hirohashi S: E-cadherin gene mutations in human gastric carcinoma cell lines. Proc Natl Acad Sci USA 91: 1858-1862, 1994.
9. Becker KF, Atkinson MJ, Reich U, Becker I, Nekarda H, Siewert JR and Hofler H: E-cadherin gene mutations provide clues to diffuse type gastric carcinomas. Cancer Res 54: 3845-3852, 1994.
10. Nelson WJ and Nusse R: Convergence of Wnt, beta-catenin, and cadherin pathways. Science 303: 1483-1487, 2004.
11. Nakamura A, Shimazaki T, Kaneko K, Shibata M, Matsumura T, Nagai M, Makino R and Mitamura K: Characterization of DNA polymorphisms in the E-cadherin gene (CDH1) promoter region. Mutat Res 502: 19-24, 2002.
12. Li LC, Chui RM, Sasaki M, Nakajima K, Perinchery G, Au HC, Nojima D, Carroll P and Dahiya R: A single nucleotide polymorphism in the E-cadherin gene promoter alters transcriptional activities. Cancer Res 60: 873-876, 2000.
13. Verhage BA, van Houwelingen K, Ruijter TE, Kiemeney LA and Schalken JA: Single-nucleotide polymorphism in the E-cadherin gene promoter modifies the risk of prostate cancer. Int J Cancer 100: 683-685, 2002.
14. Wu MS, Huang SP, Chang YT, Lin MT, Shun CT, Chang MC, Wang HP, Chen CJ and Lin JT: Association of the -160 C → a promoter polymorphism of E-cadherin gene with gastric carcinoma risk. Cancer Lett 94: 1443-1448, 2002.
15. Lei H, Sjoberg-Margolin S, Salahshor S, Werelius B, Jandakova E, Hemminki K, Lindblom A and Vorechovsky I: CDH1 mutations are present in both ductal and lobular breast cancer, but promoter allelic variants show no detectable breast cancer risk. Int J Cancer 98: 199-204, 2002.
16. Porter TR, Richards FM, Houlston RS, Evans DG, Jankowski JA, Macdonald F, Norbury G, Payne SJ, Fisher SA, Tomlinson I and Maher ER: Contribution of cyclin d1 (CCND1) and E-cadherin (CDH1) polymorphisms to familial and sporadic colorectal cancer. Oncogene 21: 1928-1933, 2002.
17. Behrens J, Lowrich O, Klein-Hitpass L and Birchmeier W: The E-cadherin promoter: Functional analysis of a GC-rich region and an epithelial cell-specific palindromic regulatory element. Proc Natl Acad Sci USA 88: 11495-11499, 1991.
18. Suriano, G, Oliveira MJ, Huntsman D, Mateus AR, Ferreira P, Casares F, Oliveira C, Carneiro F, Machado JC, Mareel M and Seruca R: E-cadherin germline missense mutations and cell phenotype: evidence for the independence of cell invasion on the motile capabilities of the cells. Hum Mol Genet 12: 3007-3016, 2003.
19. Sarriò D, Moreno-Bueno G, Hardisson D, Sanchez-Estevez C, Guo M, Herman JG, Gamallo C, Esteller M and Palacios J: Epigenetic and genetic alterations of APC and CDH1 genes in lobular breast cancer: relationships with abnormal E-cadherin and catenin expression and microsatellite instability. Int J Cancer 106: 208-215, 2003.
20. Braungart E, Schumacher C, Hartmann E, Nekarda H, Becker KF, Hofler H and Atkinson MJ: Functional loss of E-cadherin and cadherin-11 alleles on chromosome 16q22 in colonic cancer. J Pathol 187: 530-534, 1999.
21. Houlston RS and Tomlinson IP: Polymorphisms and colorectal tumor risk. Gastroenterology 121: 282-301, 2001.
22. Shin Y, Kim IJ, Kang HC, Park JH, Park HW, Jang SG, Lee MR, Jeong SY, Chang HJ, Ku JL and Park JG: A functional polymorphism (-347 G→GA) in the E-cadherin gene is associated with colorectal cancer. Carcinogenesis 25: 2173-2176, 2004.
23. Pharoah PD, Oliveira C, Machado JC, Keller G, Vogelsang H, Laux H, Becker KF, Hahn H, Paproski SM, Brown LA, Caldas C and Huntsman D: CDH1 c-160a promotor polymorphism is not associated with risk of stomach cancer. Int J Cancer 101: 196-197, 2002.
24. Park WS, Cho YG, Park JY, Kim CJ, Lee JH, Kim HS, Lee JW, Song YH, Park CH, Park YK, Kim SY, Nam SW, Lee SH, Yoo NJ and Lee JY: A single nucleotide polymorphism in the E-cadherin gene promoter-160 is not associated with risk of Korean gastric cancer. J Korean Med Sci 18: 501-504, 2003.
25. Lu Y, Xu YC, Shen J, Yu RB, Niu JY, Guo JT, Hu X and Shen HB: E-cadherin gene C-160A promoter polymorphism and risk of non-cardia gastric cancer in a Chinese population. World J Gastroenterol 11: 56-60, 2005.
26. Kuraoka K, Oue N, Yokozaki H, Kitadai Y, Ito R, Nakayama H and Yasui W: Correlation of a single nucleotide polymorphism in the E-cadherin gene promoter with tumorigenesis and progression of gastric carcinoma in Japan. Int J Oncol 23: 421-427, 2003.
27. Humar B, Graziano F, Cascinu S, Catalano V, Ruzzo AM, Magnani M, Toro T, Burchill T, Futschik ME, Merriman T and Guilford P: Association of CDH1 haplotypes with susceptibility to sporadic diffuse gastric cancer. Oncogene 21: 8192-8195, 2002.
28. Dong SM, Kim HS, Rha SH and Sidransky D: Promoter hypermethylation of multiple genes in carcinoma of the uterine cervix. Clin Cancer Res 7: 1982-1986, 2001.
29. Nishimura M, Saito T, Yamasaki H and Kudo R: Suppression of gap junctional intercellular communication via 5' CpG island methylation in promoter region of E-cadherin gene in endometrial cancer cells. Carcinogenesis 24: 1615-1623, 2003.
30. Mell LK, Meyer JJ, Tretiakova M, Khramtsov A, Gong C, Yamada SD, Montag AG and Mundt AJ: Prognostic significance of E-cadherin protein expression in pathological stage I-III endometrial cancer. Clin Cancer Res 10: 5546-5553, 2004.